(5Z)-(15S)-11alpha-Hydroxy-9,15-dioxoprostanoate (BioDeep_00000005611)

Main id: BioDeep_00000628870

 

human metabolite Endogenous


代谢物信息卡片


(5Z)-7-[(1S,2S,3S)-3-hydroxy-5-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid

化学式: C20H32O5 (352.2249622)
中文名称: 13,14-二氢-15-酮前列腺素e2
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CCCCCC(=O)CCC1C(CC(=O)C1CC=CCCCC(=O)O)O
InChI: InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,16-17,19,23H,2-3,5-6,8-14H2,1H3,(H,24,25)/b7-4-/t16-,17-,19-/m0/s1

描述信息

(5Z)-(15S)-11alpha-Hydroxy-9,15-dioxoprostanoate is a precursor in producing (5Z)-(15S)-11-a-hydroxy-9,15-dioxoprosta-13-enoate in the presence of NADP+, in this reaction (5Z)-(15S)-11alpha-Hydroxy-9,15-dioxoprostanoate is oxidized. [HMDB]
(5Z)-(15S)-11alpha-Hydroxy-9,15-dioxoprostanoate is a precursor in producing (5Z)-(15S)-11-a-hydroxy-9,15-dioxoprosta-13-enoate in the presence of NADP+, in this reaction (5Z)-(15S)-11alpha-Hydroxy-9,15-dioxoprostanoate is oxidized.

同义名列表

18 个代谢物同义名

(5Z)-7-[(1S,2S,3S)-3-hydroxy-5-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid; (5Z)-7-[(1R,2R,3R)-3-hydroxy-5-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid; (5Z)-7-[(1S,2S,3S)-3-Hydroxy-5-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoate; (5Z)-(15S)-11alpha-Hydroxy-9,15-dioxoprostanoic acid; (5Z)-11alpha-Hydroxy-9,15-dioxoprost-5-enoic acid; (5Z)-(15S)-11Α-hydroxy-9,15-dioxoprostanoic acid; (5Z)-(15S)-11alpha-Hydroxy-9,15-dioxoprostanoate; (5Z)-(15S)-11a-Hydroxy-9,15-dioxoprostanoic acid; (5Z)-11alpha-Hydroxy-9,15-dioxoprost-5-enoate; (5Z)-(15S)-11Α-hydroxy-9,15-dioxoprostanoate; (5Z)-(15S)-11a-Hydroxy-9,15-dioxoprostanoate; 9,15-dioxo-11R-hydroxy-5Z-prostenoic acid; alpha-Hydroxy-9,15-dioxoprostanoic acid; 13,14-dihydro-15-keto-Prostaglandin E2; 13,14-dihydro-15-keto Prostaglandin E2; alpha-Hydroxy-9,15-dioxoprostanoate; 13,14-dihydro-15-keto-PGE2; DHK-PGE2



数据库引用编号

13 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

3 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(3)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Dorothy K Hatsukami, Xianghua Luo, Alisa K Heskin, Mei Kuen Tang, Steven G Carmella, Joni Jensen, Jason D Robinson, Ryan Vandrey, David J Drobes, Andrew A Strasser, Mustafa al'Absi, Scott Leischow, Paul M Cinciripini, Joseph Koopmeiners, Joshua Ikuemonisan, Neal L Benowitz, Eric C Donny, Stephen S Hecht. Effects of immediate versus gradual nicotine reduction in cigarettes on biomarkers of biological effects. Addiction (Abingdon, England). 2019 10; 114(10):1824-1833. doi: 10.1111/add.14695. [PMID: 31140663]
  • Kok-Onn Lee, Edmund Feng Tian, Martin Hui Cai, Hong Wang, Yiong-Huak Chan, Meng-Kwoon Sim. Bioavailability of Orally Administered Des-Aspartate-Angiotensin I in Human Subjects. Drugs in R&D. 2018 Mar; 18(1):51-54. doi: 10.1007/s40268-017-0218-4. [PMID: 29168127]
  • Ajit Singh Mahla, Ravjibhai K Chaudhari, Atul Kumar Verma, Amit Kumar Singh, Sanjay Kumar Singh, Gyanendra Singh, Mihir Sarkar, Narayan Dutta, Harendra Kumar, Narayanan Krishnaswamy. Effect of dietary supplementation of omega-3 polyunsaturated fatty acid (PUFA) rich fish oil on reproductive performance of the goat (Capra hircus). Theriogenology. 2017 Sep; 99(?):79-89. doi: 10.1016/j.theriogenology.2017.05.023. [PMID: 28708503]
  • Julio Mesa, Cristina Alsina, Udo Oppermann, Xavier Parés, Jaume Farrés, Sergio Porté. Human prostaglandin reductase 1 (PGR1): Substrate specificity, inhibitor analysis and site-directed mutagenesis. Chemico-biological interactions. 2015 Jun; 234(?):105-13. doi: 10.1016/j.cbi.2015.01.021. [PMID: 25619643]
  • Yu-Hsiang Yu, Yi-Cheng Chang, Tseng-Hsiung Su, Jiun-Yi Nong, Chao-Chin Li, Lee-Ming Chuang. Prostaglandin reductase-3 negatively modulates adipogenesis through regulation of PPARγ activity. Journal of lipid research. 2013 Sep; 54(9):2391-9. doi: 10.1194/jlr.m037556. [PMID: 23821743]
  • Sine Nygaard Langerhuus, Else K Tønnesen, Karin H Jensen, Birthe M Damgaard, Ulrich Halekoh, Charlotte Lauridsen. Effects of dietary n-3 and n-6 fatty acids on clinical outcome in a porcine model on post-operative infection. The British journal of nutrition. 2012 Mar; 107(5):735-43. doi: 10.1017/s0007114511003503. [PMID: 21810284]
  • K Kaneko, S Kawakami. The roles of PGF(2alpha) and PGE(2) in regression of the corpus luteum after intrauterine infusion of Arcanobacterium pyogenes in cows. Theriogenology. 2009 Mar; 71(5):858-63. doi: 10.1016/j.theriogenology.2008.10.007. [PMID: 19095297]
  • George Giagoudakis, Sophia L Markantonis. Relationships between the concentrations of prostaglandins and the nonsteroidal antiinflammatory drugs indomethacin, diclofenac, and ibuprofen. Pharmacotherapy. 2005 Jan; 25(1):18-25. doi: 10.1592/phco.25.1.18.55618. [PMID: 15767216]
  • E Kankuri, K Vaali, R Korpela, I Paakkari, H Vapaatalo, E Moilanen. Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut. Inflammation. 2001 Oct; 25(5):301-10. doi: 10.1023/a:1012860509440. [PMID: 11820457]
  • A Wischral, I T Verreschi, S B Lima, L F Hayashi, R C Barnabe. Pre-parturition profile of steroids and prostaglandin in cows with or without foetal membrane retention. Animal reproduction science. 2001 Sep; 67(3-4):181-8. doi: 10.1016/s0378-4320(01)00119-1. [PMID: 11530264]
  • E Amon, K Fossick, B Sibai. Serial changes in the biophysical profile in patients undergoing cervical ripening with a controlled release PGE2 vaginal pessary. The Journal of maternal-fetal medicine. 1999 Jan; 8(1):8-11. doi: 10.1002/(sici)1520-6661(199901/02)8:1<8::aid-mfm2>3.0.co;2-0. [PMID: 10052838]
  • K Farker, H Schweer, R Vollandt, N Nassr, U Nagel, H W Seyberth, A Hoffmann, M Oettel. Measurements of urinary prostaglandins in young ovulatory women during the menstrual cycle and in postmenopausal women. Prostaglandins. 1997 Sep; 54(3):655-64. doi: 10.1016/s0090-6980(97)00131-7. [PMID: 9373880]
  • A Leonhardt, M Krauss, U Gieler, H Schweer, R Happle, H W Seyberth. In vivo formation of prostaglandin E1 and prostaglandin E2 in atopic dermatitis. The British journal of dermatology. 1997 Mar; 136(3):337-40. doi: . [PMID: 9115911]
  • S Zacharieva, I Muchá, M Wippermann, S Sheitanova, K Andonova. Lack of a specific effect of corticotropin-releasing hormone (CRH) on plasma levels of 13,14-dihydro-15-keto-prostaglandin E2 in normal subjects. Prostaglandins, leukotrienes, and essential fatty acids. 1995 Jan; 52(1):55-7. doi: 10.1016/0952-3278(95)90097-7. [PMID: 7708821]
  • S Sakuma, Y Fujimoto, Y Miyata, K Yamane, H Nishida, T Fujita. Inhibition of 15-hydroxy prostaglandin dehydrogenase activity in rabbit gastric antral mucosa by 13-hydroperoxyoctadecadienoic acid. Prostaglandins, leukotrienes, and essential fatty acids. 1994 Dec; 51(6):425-30. doi: 10.1016/0952-3278(94)90060-4. [PMID: 7708809]
  • W Heuwieser, E Grunert, H O Hoppen. Maternal and fetal prostaglandin concentrations during late gestation in dairy cattle. Prostaglandins. 1993 Jan; 45(1):35-46. doi: 10.1016/0090-6980(93)90088-o. [PMID: 8424132]
  • F Fairlie, G Phillips, M McLaren, A Calder, J Walker. Uterine activity in spontaneous labour and maternal peripheral plasma prostaglandin E2 and F2 alpha metabolites. Journal of perinatal medicine. 1993; 21(1):35-42. doi: 10.1515/jpme.1993.21.1.35. [PMID: 8487148]
  • S Zacharieva, I Muchá, J Popova, K Andonova. Different effects of growth hormone-releasing hormone (GRH) and somatostatin on growth hormone and stable metabolite of prostaglandin E2, 13, 14-dihydro-15-keto-prostaglandin E2 (PGE2-M) in normal subjects. Diabete & metabolisme. 1992 May; 18(3):209-12. doi: NULL. [PMID: 1356837]
  • P Y Hester, N F Newlon, P M Klingensmith. Plasma, follicular, and uterine levels of prostaglandins in chickens laying soft-shelled and shell-less eggs. Poultry science. 1991 Jul; 70(7):1585-93. doi: 10.3382/ps.0701585. [PMID: 1886870]
  • A V Taylor, J Boland, A L Bernal, I Z MacKenzie. Prostaglandin metabolite levels during cervical ripening with a controlled-release hydrogel polymer prostaglandin E2 pessary. Prostaglandins. 1991 Jun; 41(6):585-94. doi: 10.1016/0090-6980(91)90063-l. [PMID: 2052740]
  • W H Hesse, G Rudofsky, B A Peskar. [Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease]. Wiener klinische Wochenschrift. 1991; 103(18):554-7. doi: NULL. [PMID: 1750222]
  • N C Hill, M Selinger, J Ferguson, A López Bernal, I Z Mackenzie. The physiological and clinical effects of progesterone inhibition with mifepristone (RU 486) in the second trimester. British journal of obstetrics and gynaecology. 1990 Jun; 97(6):487-92. doi: 10.1111/j.1471-0528.1990.tb02517.x. [PMID: 2198918]
  • M Thorén, C Stenfors, B Apéria, A A Mathé. Hypothalamic-pituitary-adrenal axis interaction with prostaglandins. Progress in neuro-psychopharmacology & biological psychiatry. 1990; 14(3):319-26. doi: 10.1016/0278-5846(90)90020-h. [PMID: 2359842]
  • N C Hill, A López Bernal, J Ferguson, I Z MacKenzie. The effect of the anti-progestin mifepristone (RU 486) on plasma prostaglandin metabolite levels in early pregnancy and its influence on pregnancy termination. Acta obstetricia et gynecologica Scandinavica. 1990; 69(4):321-5. doi: 10.3109/00016349009036155. [PMID: 2244464]
  • K Bremme, P Eneroth, C Gottlieb, H Kindahl, K Svanborg, B Nilsson, M Olsson, M Bygdeman. 15-Keto-13,14-dihydroprostaglandin E2- and F2 alpha-metabolite levels in blood from men and women given prostaglandin E2 orally. Prostaglandins, leukotrienes, and essential fatty acids. 1989 Sep; 37(3):169-76. doi: 10.1016/0952-3278(89)90081-1. [PMID: 2608695]
  • J S Redfern, E Lee, M Feldman. Effect of immunization with prostaglandin metabolites on gastrointestinal ulceration. The American journal of physiology. 1988 Dec; 255(6 Pt 1):G723-30. doi: 10.1152/ajpgi.1988.255.6.g723. [PMID: 3202168]
  • N H Dubin, J C Beck, J W Johnson, W T London, R B Ghodgaonkar, M J Perlstein. Betamethasone effects on steroid and prostaglandin concentrations in pregnant rhesus monkeys. American journal of obstetrics and gynecology. 1988 Jul; 159(1):233-7. doi: 10.1016/0002-9378(88)90527-3. [PMID: 3394741]
  • H W Grant, K R Palmer, R W Kelly, N H Wilson, J J Misiewicz. Dietary linoleic acid, gastric acid, and prostaglandin secretion. Gastroenterology. 1988 Apr; 94(4):955-9. doi: 10.1016/0016-5085(88)90553-7. [PMID: 3162220]
  • H W Seyberth, T Tulassay, P G Kühl, K Soeding, W Rascher, H Schweer. Excretion of primary prostanoids and their metabolites during acute volume expansion. Prostaglandins. 1988 Feb; 35(2):221-32. doi: 10.1016/0090-6980(88)90089-5. [PMID: 3163156]
  • H Jónasson, O Augustinsson, H Kindahl. Endotoxin-induced prostaglandin (PGF2 alpha) biosynthesis, fever and miosis in dexamethasone-treated goats. Acta physiologica Scandinavica. 1987 Oct; 131(2):297-301. doi: 10.1111/j.1748-1716.1987.tb08240.x. [PMID: 3314353]
  • G S Lewis, D J Bolt. Effects of suckling, progestogen-impregnated pessaries or hysterectomy on ovarian function in autumn-lambing postpartum ewes. Journal of animal science. 1987 Jan; 64(1):216-25. doi: 10.2527/jas1987.641216x. [PMID: 2434457]
  • A A Mathe, P Bergman, B Aperia, L Wetterberg. Electroconvulsive therapy and plasma prostaglandin E2 metabolite in major depressive disorder. Progress in neuro-psychopharmacology & biological psychiatry. 1987; 11(6):701-7. doi: 10.1016/0278-5846(87)90005-4. [PMID: 2830639]
  • F A Kimball, P L Ruppel, M L Noah, J M Decoster, P delaFuente, J M Castillo, J M Hernandez. The effect of endocervical PGE2-gel (Prepidil) gel on plasma levels of 13,14-dihydro-15-keto-PGE2 (PGEM) in women at term. Prostaglandins. 1986 Oct; 32(4):527-37. doi: 10.1016/0090-6980(86)90035-3. [PMID: 3541062]
  • L Axelrod, G I Shulman, P J Blackshear, W Bornstein, A M Roussell, T T Aoki. Plasma level of 13,14-dihydro-15-keto-PGE2 in patients with diabetic ketoacidosis and in normal fasting subjects. Diabetes. 1986 Sep; 35(9):1004-10. doi: 10.2337/diab.35.9.1004. [PMID: 3091434]
  • L Axelrod, P Cornelius, J D Kieffer. Plasma eicosanoid levels in rats with nonketotic diabetes mellitus: effect of severity. Metabolism: clinical and experimental. 1986 Apr; 35(4):328-32. doi: 10.1016/0026-0495(86)90149-6. [PMID: 3083195]
  • B Rosenkranz, C Fischer, C O Meese, J C Frölich. Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man. British journal of clinical pharmacology. 1986 Mar; 21(3):309-17. doi: 10.1111/j.1365-2125.1986.tb05195.x. [PMID: 3083851]
  • W Schlegel, H Dütsch, J Urdinola, H P Schneider. The radioimmunological estimation of 13, 14-dihydro-15-ketoprostaglandin E2 in plasma and cervical mucus. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 1985 Dec; 17(12):685-8. doi: 10.1055/s-2007-1013644. [PMID: 3936765]
  • S P Brennecke, B M Castle, L M Demers, A C Turnbull. Maternal plasma prostaglandin E2 metabolite levels during human pregnancy and parturition. British journal of obstetrics and gynaecology. 1985 Apr; 92(4):345-9. doi: 10.1111/j.1471-0528.1985.tb01107.x. [PMID: 3857076]
  • R N Prasad, A C Roy, S R Kottegoda, S S Ratnam, S M Karim. Plasma levels of 13,14-dihydro-15-keto PGE2 after vaginal application of a new PGE2 film. Prostaglandins. 1985 Feb; 29(2):269-72. doi: 10.1016/0090-6980(85)90207-2. [PMID: 3856903]
  • K Goeschen, A R Fuchs, F Fuchs, P Husslein, M Rasche. [Premature membrane rupture: effect of intracervical PGE2 gel administration on plasma oxytocin, PGFM and PGEM levels in mother and child]. Geburtshilfe und Frauenheilkunde. 1984 Dec; 44(12):772-6. doi: 10.1055/s-2008-1036517. [PMID: 6597120]
  • A H Tashjian, E F Voelkel, D R Robinson, L Levine. Dietary menhaden oil lowers plasma prostaglandins and calcium in mice bearing the prostaglandin-producing HSDM1 fibrosarcoma. The Journal of clinical investigation. 1984 Dec; 74(6):2042-8. doi: 10.1172/jci111627. [PMID: 6439740]
  • I Zimmermann, B A Peskar, W T Ulmer, A A Bugalho de Almeida. Effect of histamine, acetylcholine and compound 48/80 on bronchoconstriction and release of eicosanoids in the dog. Agents and actions. 1984 Oct; 15(3-4):153-61. doi: 10.1007/bf01972342. [PMID: 6524515]
  • L Axelrod, P Cornelius. Plasma prostaglandin levels and circulating fuel levels in rats with diabetic ketoacidosis: effects of cyclooxygenase inhibitors and of alpha and beta adrenergic blockade. Prostaglandins. 1984 Sep; 28(3):333-52. doi: 10.1016/0090-6980(84)90021-2. [PMID: 6440213]
  • A R Fuchs, K Goeschen, A B Rasmussen, J V Rehnström. Cervical ripening and plasma prostaglandin levels. Comparison of endocervical and extra-amniotic PGE2. Prostaglandins. 1984 Aug; 28(2):217-27. doi: 10.1016/0090-6980(84)90058-3. [PMID: 6594722]
  • P Husslein, R Reichel, K Göschen, M Rasche, H Sinzinger. Plasma concentration of 13,14-dihydro-15-keto-PGE2 (PGEM) after various ways of cervix ripening with PGE2. Prostaglandins. 1984 Aug; 28(2):209-15. doi: 10.1016/0090-6980(84)90057-1. [PMID: 6594721]
  • M Starczewski, R Voigtmann, B A Peskar, B M Peskar. Plasma levels of 15-keto-13,14-dihydro-prostaglandin E2 in patients with bronchogenic carcinoma. Prostaglandins, leukotrienes, and medicine. 1984 Mar; 13(3):249-58. doi: 10.1016/0262-1746(84)90037-4. [PMID: 6585845]
  • P Husslein, H Sinzinger. Concentration of 13,14-dihydro-15-keto-prostaglandin E2 in the maternal peripheral plasma during labour of spontaneous onset. British journal of obstetrics and gynaecology. 1984 Mar; 91(3):228-31. doi: 10.1111/j.1471-0528.1984.tb04757.x. [PMID: 6704346]
  • P Husslein. [The importance of oxytocin and prostaglandins to the mechanism of labor in humans]. Wiener klinische Wochenschrift. Supplementum. 1984; 155(?):1-32. doi: . [PMID: 6099005]
  • D J Meuten, G J Kociba, C C Capen, D J Chew, G V Segre, L Levine, A H Tashjian, E F Voelkel, L A Nagode. Hypercalcemia in dogs with lymphosarcoma. Biochemical, ultrastructural, and histomorphometric investigations. Laboratory investigation; a journal of technical methods and pathology. 1983 Nov; 49(5):553-62. doi: . [PMID: 6314038]
  • L M Demers, S P Brennecke, L A Mountford, J D Brunt, A C Turnbull. Development and validation of a radioimmunoassay for prostaglandin E2 metabolite levels in plasma. The Journal of clinical endocrinology and metabolism. 1983 Jul; 57(1):101-6. doi: 10.1210/jcem-57-1-101. [PMID: 6853670]
  • B L O'Dell, J D Browning, P G Reeves. Plasma levels of prostaglandin metabolites in zinc-deficient female rats near term. The Journal of nutrition. 1983 Apr; 113(4):760-5. doi: 10.1093/jn/113.4.760. [PMID: 6687606]
  • J D Browning, P G Reeves, B L O'Dell. Effect of zinc deficiency and food restriction on the plasma levels of prostaglandin metabolites in male rats. The Journal of nutrition. 1983 Apr; 113(4):755-9. doi: 10.1093/jn/113.4.755. [PMID: 6687605]
  • S Gottleib, R K Rude, C F Sharp, F R Singer. Humoral hypercalcemia of malignancy: a syndrome in search of a hormone. The American journal of medicine. 1982 Nov; 73(5):751-5. doi: 10.1016/0002-9343(82)90419-3. [PMID: 6291389]
  • L Axelrod, L Levine. Plasma prostaglandin levels in rats with diabetes mellitus and diabetic ketoacidosis. Diabetes. 1982 Nov; 31(11):994-1001. doi: 10.2337/diacare.31.11.994. [PMID: 6816644]
  • M E Berger, M S Golub, J R Sowers, A S Brickman, M Nyby, H Troyer, R K Rude, F R Singer, R Horst, L J Deftos. Hypercalcemia in association with a Leydig cell tumor in the rat: a model for tumor-induced hypercalcemia in man. Life sciences. 1982 May; 30(18):1509-15. doi: 10.1016/0024-3205(82)90237-5. [PMID: 6281603]
  • S L Swartz, G H Williams. Angiotensin-converting enzyme inhibition and prostaglandins. The American journal of cardiology. 1982 Apr; 49(6):1405-9. doi: 10.1016/0002-9149(82)90351-4. [PMID: 6280473]
  • W Bothwell, M Verburg, M Wynalda, E G Daniels, F A Fitzpatrick. A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics. The Journal of pharmacology and experimental therapeutics. 1982 Feb; 220(2):229-35. doi: . [PMID: 6948952]
  • W C Hubbard. Quantitation of 15-Keto-13,14-dihydro-PGE2 in plasma by GC-MS1. Methods in enzymology. 1982; 86(?):571-8. doi: 10.1016/0076-6879(82)86227-7. [PMID: 7132770]
  • L M Cagen, S M Lanier, P G Baer. Prostaglandin E2 metabolism by isolated kidneys of New Zealand genetically hypertensive and normotensive rats. Biochemical medicine. 1981 Feb; 25(1):98-105. doi: 10.1016/0006-2944(81)90065-x. [PMID: 7225102]
  • W S Powell. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins. 1980 Nov; 20(5):947-57. doi: 10.1016/0090-6980(80)90144-6. [PMID: 6258197]
  • E Granström, M Hamberg, G Hansson, H Kindahl. Chemical instability of 15-keto-13,14-dihydro-PGE2: the reason for low assay reliability. Prostaglandins. 1980 Jun; 19(6):933-57. doi: 10.1016/0090-6980(80)90127-6. [PMID: 7384561]
  • W C Hubbard, A J Hough, R M Johnson, J A Oates. The site of VX2 tumor transplantation affects the development of hypercalcemia in rabbits. Prostaglandins. 1980 Jun; 19(6):881-9. doi: 10.1016/0090-6980(80)90122-7. [PMID: 7384559]
  • K Bremme, H Kindahl, K Svanborg. Induction of labor by oral PGE2 administration--evaluation of different dose schedules. Acta obstetricia et gynecologica Scandinavica. Supplement. 1980; 92(?):5-10. doi: NULL. [PMID: 6934685]
  • S A Metz, M G Rice, R P Robertson. Radioimmunoassay for 13,14-dihydro,15-keto-prostaglandin E2 in human plasma: applications and artifacts. Advances in prostaglandin and thromboxane research. 1980; 6(?):183-5. doi: NULL. [PMID: 7386256]